- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02996604
Acupuncture for Functional Dyspepsia: a Functional Magnetic Resonance Imaging (fMRI) Study
April 5, 2018 updated by: Chengdu University of Traditional Chinese Medicine
He-Mu-point combination(ST36 and CV12) is one of the most commonly used acupoints combination with synergistic effect for functional dyspepsia(FD).
The investigators design the trial to identify the efficacy and explore the central integrated mechanism of puncturing at He-Mu-point combination on FD with functional magnetic resonance imaging (fMRI).
Study Overview
Detailed Description
105 participants with functional dyspepsia will be allocated into three groups: Low-He point group, Mu point group and He-Mu-point combination group.Every participant will receive 20 sessions of manual acupuncture treatment during 4 weeks.
Clinical evaluations will be assessed three times, as measured after randomization, 10 and 20 sessions of treatment.The fMRI scans will be conducted twice, after randomization and treatment completion.
Study Type
Interventional
Enrollment (Actual)
105
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610000
- Chengdu University of Traditional Chinese Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- right handed,age between 18 and 45 years old, college degree or above;
- match the Rome III criteria on FD;
- no local organic disease by gastroscope examination;
- before entering the study, without taking any prokinetic agents at least 15days and participating in other clinical study;
- signing an informed consent in writing by the participant or the immediate family member.
Exclusion Criteria:
- consciousness, cannot express subjective symptoms and psychiatric participants;
- participants with advanced cancer or other serious wasting diseases, easy to be infected and bleeding;
- complicating with severe cardiovascular, hepatic,nephritic,digestive, hematopoietic system diseases;
- impregnate or lactation female;
- severe depression and anxiety symptoms;
- female with serious dysmenorrhea;
- obvious headache, migraine, history of head injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low-He point(ST36)
Zusanli (ST36, the Low-He point of stomach) is the most important point for gastrointestinal disorder, including functional dyspepsia.
Everyone in the group will be punctured at unilateral Zusanli.
|
Manual acupuncture treatment will be conducted.
thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
|
Experimental: Mu point(CV12)
Zhongwan (CV12, the Mu point of stomach) is also good at regulating gastric function.
Everyone in the group will be punctured at Zhongwan.
|
Manual acupuncture treatment will be conducted.
thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
|
Active Comparator: He-Mu-point combination(ST36 and CV12)
In traditional Chinese acupuncture theory,synergistic effect can be produced by acupoints combination and the He-Mu-point combination is a classical acupoints combination formula for gastrointestinal diseases.
Everyone in the group will be punctured at unilateral Zusanli and Zhongwan.
|
Manual acupuncture treatment will be conducted.
thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Nepean Dyspepsia Index (NDI)
Time Frame: 4 weeks after allocation
|
4 weeks after allocation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Self-Rating Anxiety Scale
Time Frame: 0 day,2, 4weeks after allocation
|
0 day,2, 4weeks after allocation
|
Self-Rating Depression Scale
Time Frame: 0 day,2, 4weeks after allocation
|
0 day,2, 4weeks after allocation
|
Leeds dyspepsia questionnaire
Time Frame: 0 day,4 weeks after allocation
|
0 day,4 weeks after allocation
|
brain MRI data
Time Frame: 0 day,4weeks after allocation
|
0 day,4weeks after allocation
|
The incidence of adverse events during the 4 weeks
Time Frame: 4weeks after allocation
|
4weeks after allocation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Fang Zeng, professor, Chengdu University of Traditional Chinese Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
December 15, 2016
First Submitted That Met QC Criteria
December 15, 2016
First Posted (Estimate)
December 19, 2016
Study Record Updates
Last Update Posted (Actual)
April 6, 2018
Last Update Submitted That Met QC Criteria
April 5, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15QNJJ0008
- 81473602 (Other Grant/Funding Number: National Scientific Foundation Committee of China)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Dyspepsia
-
King Chulalongkorn Memorial HospitalRecruiting
-
Wuhan Central HospitalNot yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruitingFunctional DyspepsiaKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
Hong Kong Baptist UniversityXiyuan Hospital of China Academy of Chinese Medical SciencesRecruitingFunctional DyspepsiaHong Kong
-
Seoul National University HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Wonju Severance Christian HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedFunctional DyspepsiaKorea, Republic of
Clinical Trials on acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting